Could blood vessel damage help explain the many symptoms of #LongCOVID?

Prof Resia Pretorius and Prof Doug Kell discuss their research into abnormal clots, inflammation and vascular damage, and how these changes may affect the microcirculation and oxygen delivery.

#ISLCPAIS #LongCOVIDResearch

Why don’t all #LongCOVID studies tell the same story?

Dr Odilia Corneth explains why different patient groups may show different biological patterns, and why disease duration matters.

Understanding these differences could be key to more targeted treatments.

#ISLCPAIS #MEcfs

Could the gut play a bigger role in #LongCOVID and #MEcfs?

Prof Eva Untersmayr explains how changes to the gut barrier and microbiome may contribute to low-grade inflammation.

Her team has found these changes in both Long COVID and ME/CFS patients.

#ISLCPAIS #LongCOVIDResearch

At the #ISLCPAIS on Aug 27, 2027 at the conference in Amsterdam, Dr. Rae Duncan speaks to the distinguished differences between #LC & other PAIS.
#LongCovidAwareness

What happens when recovery remains out of reach?

Dr Odelia Corneth followed severely affected #LongCOVID patients for ~2½ years. Many had PEM, were homebound and functioning at just 20–30% of their pre-COVID level.

Only a handful showed improvement.

#ISLCPAIS #MEcfs

Could abnormal blood clots help explain #LongCOVID?

Prof Doug Kell and Prof Resia Pretorius discuss research into amyloid, fibrin and abnormal clots, and how spike protein may contribute to changes in clot structure.

Could this help explain persistent symptoms?

#ISLCPAIS